Understanding how Wnt signaling affects eye health in age-related macular degeneration
Dysregulation of Wnt signaling in subretinal fibrosis in AMD
This study is looking into how changes in a specific signaling pathway might affect eye health in people with age-related macular degeneration (AMD), with the hope of finding new ways to help manage or prevent this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-11092181 on NIH RePORTER |
What this research studies
This research investigates the role of Wnt signaling in age-related macular degeneration (AMD), a condition that can lead to vision loss. The study aims to understand how dysregulation of this signaling pathway contributes to retinal inflammation and other complications associated with AMD. By examining animal models and human samples, researchers will explore the mechanisms behind Wnt signaling changes and their impact on retinal health. The ultimate goal is to identify potential therapeutic targets that could help manage or prevent AMD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with age-related macular degeneration, particularly those experiencing retinal inflammation or related complications.
Not a fit: Patients with other forms of macular degeneration or those without retinal issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve vision and quality of life for patients with age-related macular degeneration.
How similar studies have performed: Previous research has shown promising results in targeting Wnt signaling pathways for treating retinal diseases, indicating that this approach may be effective.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Takahashi, Yusuke — Wake Forest University Health Sciences
- Study coordinator: Takahashi, Yusuke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.